"""
Classifies: CHEBI:27933 beta-lactam antibiotic
"""
Based on the previous program and the provided outcomes, it appears that the current approach is not sufficient to accurately classify beta-lactam antibiotics. The program misses several true positive examples, indicating that the implemented rules are too strict and need to be revised.

Here's a breakdown of the issues and possible improvements:

1. **Missing beta-lactam ring detection**: The SMARTS pattern used for detecting the beta-lactam ring ([C&R]2(=[O])[NR1][C&R]([C&R]2=[O])=[O]) might be too specific and not capturing all variations of the beta-lactam ring system. It would be better to use a more general pattern that accounts for different substituents and ring configurations.

2. **Overreliance on specific substructures**: The program heavily relies on the presence of specific substructures like thiazolidine, dihydrothiazine, and furan rings to classify penicillins and cephalosporins. While these substructures are common in these classes, they are not present in all beta-lactam antibiotics. The program should focus more on the presence of the beta-lactam ring and other common features rather than relying too heavily on specific substructures.

3. **Missing structural diversity**: Beta-lactam antibiotics can have a wide range of structural variations, and the program does not account for many of them. It might be helpful to analyze the false negatives and identify additional structural features or patterns that could be incorporated into the classification rules.

4. **Overconfidence in specific features**: The program considers the presence of a carboxylic acid group and an amino group as sufficient for classifying a molecule as a beta-lactam antibiotic. However, these functional groups are common in many other classes of molecules as well, and their presence alone should not be considered definitive evidence for beta-lactam antibiotics.

To improve the program, you could consider the following approaches:

1. **Use a more general beta-lactam ring pattern**: Explore different SMARTS patterns or other methods to detect the beta-lactam ring in a more comprehensive manner. Consider accounting for different substituents, ring conformations, and variations.

2. **Incorporate additional structural features**: Analyze the false negatives and identify common structural features or patterns that could be useful for classification. These could include specific functional groups, ring systems, or specific atom environments.

3. **Use machine learning techniques**: Instead of relying solely on predefined rules, you could explore machine learning techniques to learn the patterns and features that distinguish beta-lactam antibiotics from other molecules. This approach could potentially capture more complex and diverse structural patterns.

4. **Consider molecular descriptors**: In addition to substructure matching, you could incorporate molecular descriptors such as molecular weight, logP, or topological indices, which might provide additional discriminative power for classification.

5. **Refine the classification logic**: Review the classification logic and prioritize the presence of the beta-lactam ring as the primary criterion. Other features like functional groups or specific substructures should be used as supporting evidence rather than strict requirements.

By incorporating these improvements, the program should be better equipped to handle the structural diversity of beta-lactam antibiotics and provide more accurate classifications.